Advancis Pharmaceutical Corp., of Germantown, Md., promoted Kevin Sly to chief business officer.
Adventrx Pharmaceuticals Inc., of San Diego, appointed Cellia Habita vice president of clinical and medical affairs.
Aesgen Inc., of Princeton, N.J., appointed Jason Spitz vice president of marketing and sales.
Alfacell Corp., of Bloomfield, N.J., appointed Andrew Savadelis chief financial officer and senior vice president of finance.
Amgen Inc., of Thousand Oaks, Calif., appointed Leonard Schaeffer to its board, and nominated Frank Herringer.
Anacor Pharmaceuticals Inc., of Palo Alto, Calif., appointed Jacob Plattner senior vice president of research and development.
Australian Cancer Technology, of Rochester, N.Y., appointed Tom Milicevic chief financial officer and secretary.
Barrington Associates, of Los Angeles, hired Paul Kacik as senior vice president and head of health care investment banking.
BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointed Carl Gordon to its board.
Cangene Corp., of Toronto, appointed John McMillan chief financial officer on an interim basis.
Cel-Sci Corp., of Vienna, Va., appointed John Cipriano senior vice president of regulatory affairs.
Chromatin Inc., of Chicago, appointed Anthony Cavalieri to the board.
Ciphergen Biosystems Inc., of Fremont, Calif., named William Sullivan vice president of diagnostic operations.
Compound Therapeutics Inc., of Waltham, Mass., appointed John Edwards vice president of commercial development.
Dynavax Technologies Corp., of Berkeley, Calif., appointed Kevin Kwok vice president and chief business officer, and Denise Gilbert to its board.
Epoch Biosciences Inc., of Bothell, Wash., appointed Janet Whitmore to its board.
Exelixis Inc., of South San Francisco, appointed Jack Wyszomierski to its board.
GeneMax Corp., of Vancouver, British Columbia, appointed Terry Pearson and Norman MacKinnon to its board.
Genentech Inc., of South San Francisco, promoted Susan Hellmann to president of product development, Myrtle Potter to president of commercial operations and David Ebersman to a member of the executive committee.
Genitope Corp., of Redwood City, Calif., appointed Claude Miller vice president of quality.
GTx Inc., of Memphis, Tenn., appointed Andrew Clarkson and Kenneth Glass to its board.
Hudson Health Sciences Inc., of South San Francisco, elected Leon Rosenberg and Isaac Kier to its board. It also appointed Fred Vitale vice president of business development.
Human Genome Sciences Inc., of Rockville, Md., appointed Kathryn Falberg and Augustine Lawlor to its board and audit committee.